MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr |
What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-12,683 Cr |
| Mar2024 | ₹-2,082 Cr |
| Mar2023 | ₹-1,054 Cr |
| Mar2022 | ₹-1,369 Cr |
| Mar2021 | ₹-1,222 Cr |
How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-12,683 Cr | Negative | |
| Mar2024 | ₹-2,082 Cr | Negative | |
| Mar2023 | ₹-1,054 Cr | Negative | |
| Mar2022 | ₹-1,369 Cr | Negative | |
| Mar2021 | ₹-1,222 Cr | - | |
Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹91,067.8 Cr | -1.9% | -8.2% | -13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,248.0 Cr | -0.2% | 5.8% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,344.0 Cr | -0.6% | -5.2% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,832.0 Cr | -0.5% | 2.5% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,820.0 Cr | -1.1% | -0.2% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,877.0 Cr | 2.4% | 7% | 6.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.9% |
-8.2% |
-13.5% |
| SENSEX | -0.6% |
1.4% |
7.7% |
You may also like the below Video Courses